Cancer drug dasatinib shows promise in shrinking HIV's hidden stash
Disease control
Completed
This study tested whether a low dose of dasatinib, a drug used for leukemia, is safe and can reduce inflammation and the amount of hidden HIV in people already on effective HIV treatment. Sixty adults with well-controlled HIV took either dasatinib or a placebo daily for 24 weeks …
Phase: PHASE2 • Sponsor: Fundació Institut Germans Trias i Pujol • Aim: Disease control
Last updated May 26, 2026 09:01 UTC